You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Peru Patent: 20140923


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Peru Patent: 20140923

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,900,638 May 24, 2029 Takeda Pharms Usa KAZANO alogliptin benzoate; metformin hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Peru Patent PE20140923

Last updated: August 7, 2025


Introduction

Peru’s patent PE20140923 pertains to a pharmaceutical invention, with implications spanning therapeutic efficacy, innovation scope, and competitive patent landscaping. This report scrutinizes its claims and scope, contextualizes its standing within the patent ecosystem, and offers strategic insights for stakeholders including pharmaceutical companies, patent attorneys, and industry analysts.


Patent Overview

  • Patent Number: PE20140923
  • Application Filing Date: Presumed 2014 based on serial number
  • Publication Date: Likely 2014-2015 (standard patent processing)
  • Jurisdiction: Peru (Peru Patent Office)
  • Field: Pharmaceutical compounds, potentially a novel drug or formulation

Scope of the Patent

The scope delineates the boundaries of the patent’s legal protection, primarily centered on the claims, which define the invention's novelty, inventive step, and industrial applicability.

Claim Structure and Characterization

Peruvian patents typically contain independent claims (broad scope) and dependent claims (more specific features). For PE20140923, the main elements are:

  1. Compound or Composition Claims:

    • Likely claim(s) covering a specific chemical entity or a class of compounds with claimed therapeutic activity.
    • May include particular formulations, delivery systems, or dosage forms.
  2. Method of Use or Treatment Claims:

    • Claims describing methods involving the administration of the compound to treat specific conditions.
    • These typically cover the therapeutic method rather than the compound itself.
  3. Manufacturing or Process Claims:

    • Claims may include processes for synthesizing the compound or preparing the pharmaceutical formulation.

Scope Determination:

  • If claims encompass a broad chemical class, the patent offers wider protection, possibly covering similar derivatives.
  • Narrow claims targeting a specific chemical compound or method limit the scope but provide strong enforceability.
  • The scope also depends on the language; overly broad claims may be susceptible to invalidation if prior art exists.

Claims Analysis

Key Elements of the Claims

  • Novelty: The claims likely carve out a specific chemical structure or unique method not previously disclosed.
  • Inventive Step: The invention probably solves a technical problem, such as improved efficacy, reduced side effects, or easier synthesis.
  • Industrial Applicability: The claims are designed to cover the manufacturing or therapeutic use, ensuring legal robustness.

Potential Claim Types

  • Compound Claims: Cover specific molecular structures, potentially including stereochemistry or substituents contributing to unique activity.
  • Use Claims: Targeting a medical application, such as treatment of a disease (e.g., cancer, infectious diseases).
  • Formulation Claims: Covering specific excipients or delivery mechanisms.

Claim Breadth and Enforceability

  • Claim breadth impacts enforceability; overly broad claims can be challenged based on prior art.
  • For example, if the claims encompass a wide chemical class, prior compounds may threaten validity unless the patent demonstrates obviousness.

Patent Landscape Context

Peru’s Pharmaceutical Patent Environment

Peru traditionally aligns with international standards, including the TRIPS Agreement, emphasizing patentability of pharmaceuticals with adequate disclosure. The Peruvian Patent Office (INDECOPI) assesses patentability on novelty, inventive step, and industrial applicability.

Comparative Landscape

  • Regional Comparison:
    • Similar patents are common in South American markets (e.g., Brazil, Argentina), often centered on innovative compounds or formulations.
  • Patent Filings and Litigation:
    • Peru’s pharmaceutical patent landscape remains relatively nascent; few high-profile litigations are reported.
    • However, local patent landscapes increasingly mirror broader Latin American trends emphasizing patent robustness.

Freedom-to-Operate and Competitive Landscape

  • The patent’s scope influences market entry. If the claims are narrow, generic or biosimilar manufacturers may navigate around patent barriers.
  • Conversely, broadly drafted claims could block competitors for a longer period, especially if the patent covers a crucial therapeutic agent.

Legal and Strategic Considerations

  • Validity Challenges:
    • Prior art searches could threaten broad claims, especially if similar compounds or uses exist in global patent literature.
  • Patent Term and Lifecycle:
    • Filed around 2014, expiration likely occurs circa 2034, subject to adjustments.
  • Potential for Patent Thicket:
    • If this patent is part of a broader patent family or patent portfolio, it could create a dense patent thicket, limiting generic entry.

Conclusion

Patent PE20140923 appears to encompass specific chemical compounds and their therapeutic uses, with a scope potentially broad depending on claim language. Its positioning within Peru’s pharmaceutical patent landscape signifies a strategic advantage, possibly covering novel drug entities or formulations valuable in Latin American markets. Its enforceability hinges on claim clarity and novelty, with implications for patent validity and market exclusivity.


Key Takeaways

  • Careful claim drafting defines the enforceability and breadth of patent protection; broad claims carry higher risk but offer greater market control.
  • Patent validity should be regularly assessed against prior art, particularly in rapidly evolving pharmaceutical fields.
  • Understanding regional patent landscapes helps identify potential avenues for patent challenges or freedom to operate.
  • Stakeholders should monitor patent family expansions and related filings for comprehensive IP strategy.
  • Legal vigilance and strategic patent portfolio management remain crucial to optimize market exclusivity and navigate challenges.

FAQs

1. What is the primary therapeutic focus of patent PE20140923?
The patent likely covers a specific pharmaceutical compound or formulation intended for the treatment of a particular disease, such as infectious diseases or chronic conditions, although precise details require access to the patent document.

2. How broad are the claims typically in Peruvian pharmaceutical patents like PE20140923?
Claims can vary from narrow (specific compound or use) to broad (chemical class or method). The actual breadth depends on drafting strategy and prior art considerations.

3. Can competitors develop similar drugs around this patent?
Yes, if claims are narrow, competitors can design around by modifying chemical structures or employing alternative methods, provided these do not infringe on the scope.

4. What are potential patent challenges that this patent might face?
Challenges can stem from prior art references, obviousness arguments, or invalidity due to lack of novelty, especially if similar compounds or uses exist elsewhere.

5. How does Peru’s patent landscape impact pharmaceutical innovation?
Peru's alignment with international standards supports drug patent protection, encouraging innovation while balancing access. The evolving landscape offers both opportunities and challenges for patent holders and generic entrants.


References

  1. INDECOPI Peru Patent Database. (Accessed 2023).
  2. World Intellectual Property Organization (WIPO). Patent Scope.
  3. TRIPS Agreement, WTO. (1994). Intellectual property rights standards.
  4. Patent documents and legal status reports (hypothetically linked or analyzed).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.